Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Oncology Track

  • You have access
    Characterization and acute toxicity of alginate hydrogel for combined radiochemotherapy
    Ali Azhdarinia, Dong-Fang Yu, David Yang, Richard Mendez, Jerry Bryant and E Kim
    Journal of Nuclear Medicine May 1, 2006, 47 (suppl 1) 490P;
  • You have access
    Correlation of I-131 Tositumomab biodistribution and FDG PET positivity in patients treated with Bexxar for non-Hodgkins lymphoma
    Russ Kuker, Aldo Serafini, Iliana Mirabolo, Sana Nini and George Sfakianakis
    Journal of Nuclear Medicine May 1, 2006, 47 (suppl 1) 484P;
  • You have access
    Increment of FDG uptake as a function of time in malignant pleural mesothelioma: Relationship to tumor invasion, metastasis, and prognosis
    Victor Gerbaudo, Marcelo Mamede, Raphael Bueno and David Sugarbaker
    Journal of Nuclear Medicine May 1, 2006, 47 (suppl 1) 474P;
  • You have access
    Bone marrow dosimetry in peptide receptor radionuclide therapy with [Lu-177-DOTA0,Tyr3]octreotate
    Flavio Forrer, Eric Krenning, Peter Kooy, Bert Bernard, Willem Bakker and Dik Kwekkeboom
    Journal of Nuclear Medicine May 1, 2006, 47 (suppl 1) 486P;
  • You have access
    Pitfalls in interpretation of C-11 Choline PET and PET/CT in urinary tract and prostate cancer
    Marina Orevi, Ofer Gofrit, Nanette Freedman, Eyal Mishani, Martine Klein, Moshe Bocher, Rami Marciano, Yodphat Krausz and Roland Chisin
    Journal of Nuclear Medicine May 1, 2006, 47 (suppl 1) 480P;
  • You have access
    The usefulness of 18F-FDG PET to discriminate between malignant and benign nodule in patients with underlying idiopathic pulmonary fibrosis
    Bom Sahn Kim, Won Jun Kang, Sujin Jang, Sung June Jang, Angela Park, Dong Soo Lee, June-Key Chung and Myung Chul Lee
    Journal of Nuclear Medicine May 1, 2006, 47 (suppl 1) 471P;
  • You have access
    Location-based comparison of F-18 FDG PET and bone scan for detection of bone metastasis in patients with non-small cell lung cancer
    Min Jeong Chae, Gi Jeong Cheon, Byung Hyun Byun, Sang Woo Lee, Chang Woon Choi and Sang Moo Lim
    Journal of Nuclear Medicine May 1, 2006, 47 (suppl 1) 470P;
  • You have access
    Quantitative imaging analysis of high dose I-131 anti-CD20 monoclonal antibody (rituximab) therapy in patients with non-Hodgkin’s lymphoma
    Kyeong Min Kim, Jeong Wan Kwon, Tae Hyun Choi, Sang Hyun Cho, Byung Hyun Byun, Gi Jeong Cheon, Hye Jin Kang, Chang Woon Choi, Yeon Hee Park and Sang Moo Lim
    Journal of Nuclear Medicine May 1, 2006, 47 (suppl 1) 485P;
  • You have access
    18F-FDG PET in the evaluation of head and neck squamous cell carcinoma of unknown primary
    Conor Heaney, Val Lowe and Dimitrios Karantanis
    Journal of Nuclear Medicine May 1, 2006, 47 (suppl 1) 469P;
  • You have access
    Evaluation of response on treatment patients with progressive metastatic NETs using 90Y DOTA TATE
    Jaroslaw Cwikla, Anna Nasierowska-Guttmejer, Nina Seklecka, Krzysztof Jeziorski and Jerzy Walecki
    Journal of Nuclear Medicine May 1, 2006, 47 (suppl 1) 485P;

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 46
SNMMI

© 2025 SNMMI

Powered by HighWire